Ascertain
PrivateLast Round
Series B
Oct 19, 2026
Total Funding Raised
$130M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Ascertain operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B round in October 2026.
Ascertain is a healthcare technology company that provides an AI-powered automation platform to help health systems, payers, and provider groups streamline administrative operations.
Sector
Healthcare & Life Sciences
Verticals
Workflow Automation, Revenue Cycle, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ascertain Comparables
Compare Ascertain with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prosper Tech, Inc. | 87% | |
| Ethermed | 86% | |
| Humata Health | 86% |
For institutional investors. Book with your work email.
Ascertain Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 19, 2026 | ||||
| Series A | Apr 22, 2025 | ||||
| Early Funding | Mar 11, 2024 | ||||
| Seed | Apr 12, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ascertain Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A |
| Aegis Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 19, 2026
$20M round raised
- Jul 2, 2026
Grew 33% QoQ from 45 to 60 employees.
For institutional investors. Book with your work email.
Ascertain Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ascertain's valuation, stock price, and market status.
Is Ascertain a public or private company?
Ascertain is a private company.
What is the current stock price of Ascertain?
Ascertain is a private company, so its shares have no public market price. Caplight tracks Ascertain's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ascertain worth (valuation)?
Valuation information for Ascertain is not publicly available.
Can I buy Ascertain stock?
Ascertain shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ascertain's last funding round?
Ascertain's most recent funding round was Series B on October 19, 2026.
Who are the main investors in Ascertain?
Key investors in Ascertain include Deerfield Management.
Will Ascertain IPO soon?
No public IPO plans have been announced for Ascertain.
How can I track Ascertain secondary market activity?
Caplight tracks bids, offers, and trades in Ascertain's shares on secondary markets.